Name

lenva­tinibMe­sy­late

Syn­onyms

lenvatinibMethanesulfonate;E7080Mesylate;4-[3-Chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-6-quinolinecarboxamidemonomethanesulfonate;4-[3chloro-4-(N’-cyclopropylureido)phenoxy]-7-methoxyquinoline-6-carboxamidemethanesulfonate;lenvatinibMesylate

Mol­e­c­u­lar Formula

C22H23ClN4O7S

Mol­e­c­u­lar Weight

522.95862

CAS Num­ber (Or Wat­son Num­ber for Non-CAS Products)

857890-39-2

EINECS

1592732-453-0

Appear­ance

Specs/​Standards

98%

Use

lenva­tinibMe­sy­late Inter­me­di­ate.

Links

This prod­uct is devel­oped by our R&D com­pa­ny Cam­ing Phar­ma­ceu­ti­cal Ltd (http://​www​.cam​ing​.com/), and here is the cor­re­spond­ing link http://​cam​ing​.com/​l​e​n​v​a​t​i​n​i​b​M​e​s​y​l​a​t​e​-​c​a​s​-​8​5​7​8​9​0​-​3​9​-2/

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you shortly. 

























    Please prove you are human by select­ing the key.




    Dis­claimer

    This prod­uct is for research and devel­op­ment pur­pose only which may not be used direct­ly as drugs, food, cos­met­ics or for any oth­er non-R&D pur­pose. It may be tox­ic or haz­ardous, and should be han­dled only by qual­i­fied indi­vid­u­als trained in lab­o­ra­to­ry pro­ce­dures. The buy­er will be respon­si­ble to warn and inform any per­son that may be in con­tact with the prod­uct of the poten­tial risks and haz­ards, as well as to ensure that pur­chase, use and dis­pos­al of the prod­uct com­ply with local laws and regulations.